PATENT CLAIM ANALYSIS

Application Number: 16127832
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "289000"]

Abstract:
This disclosure relates to methods administering various compounds in conjunction with dextromethorphan to a human being. Dosage forms, drug delivery systems, and methods related to dextromethorphan or dextrorphan and bupropion, hydroxybupropion, erythrohydroxybupropion, threohydroxybupropion, or a metabolite or prodrug of any of these compounds are also disclosed

Claim (Index 16):
The method of  claim 1 , wherein the dosage form is a solid.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 97.0
- Lexical Diversity: 1.39474
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15647069', '15688660', '15621882', '15182253', '15599163']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8907973126544682
- 35 USC 102 Novelty (BERT): 0.6122284999851164
- Combined Prediction Score: 0.8629404313875331
- Mean Citation Score: 690.01053
- Max Citation Score: 695.5606700000003
- Similarity Product: 475.51027947964445

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test